(Q46881160)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395297%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Glial-neuronal interactions are impaired in the schizophrenia model of repeated MK801 exposure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395297%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395297%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

6

Ursula Sonnewald

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395297%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Eiliv Brenner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395297%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Elvar M Eyjolfsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395297%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Katarina Ryden Markinhuhta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395297%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Maria L Carlsson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395297%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

14 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395297%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395297%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395297%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395297%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

1880-1887

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395297%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300993

15 January 2020

exact match

0 references

cites work

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

N-acetylaspartate in the vertebrate brain: metabolism and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Impaired glutamine metabolism in NMDA receptor hypofunction induced by MK801.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Parallel recovery of MK-801-induced spatial learning impairment and neuronal injury in male mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Schizophrenia: from dopamine to glutamate and back

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Glutathione pathways in the brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

MK-801-induced neuronal damage in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Glutathione and signal transduction in the mammalian CNS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Glutamine synthetase activity and glutamine content in brain: modulation by NMDA receptors and nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Functional NMDA Receptor Subtype 2B Is Expressed in Astrocytes after IschemiaIn Vivoand AnoxiaIn Vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Cerebral metabolic changes induced by MK-801: a 1D (phosphorus and proton) and 2D (proton) in vivo NMR spectroscopy study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Excitatory amino acids and neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Pyruvate carboxylase: an astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Neuronal glial interaction in different neurological diseases studied by ex vivo 13C NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Direct demonstration by [13C]NMR spectroscopy that glutamine from astrocytes is a precursor for GABA synthesis in neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Evaluating glutamatergic transmission in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Approaches to studies on neuronal/glial relationships by 13C-MRS analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Preferential utilization of acetate by astrocytes is attributable to transport.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

MK-801 neurotoxicity in male mice: histologic effects and chronic impairment in spatial learning.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021

Disseminated corticolimbic neuronal degeneration induced in rat brain by MK-801: potential relevance to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300993

7 January 2021